GHK-cu

Clinical trials on GHK‑Cu have been limited but consistently positive — with the strongest evidence in topical skin repair and post‑procedure healing. Human studies show improvements in wound healing speed, inflammation reduction, collagen production, and visible anti‑ageing outcomes. No completed trials exist for injectable/systemic use.

Below is a structured, evidence‑based breakdown grounded in the search results you triggered

1. What human clinical trials have actually shown

Topical wound‑healing trials

• A 2024 multicentre clinical study tested 0.05% GHK‑Cu gel after fractional laser resurfacing. Findings:

  • 25% faster epithelial recovery

  • Reduced erythema within 72 hours

  • ~30% reduction in IL‑1β and TNF‑α, confirming measurable anti‑inflammatory action

Cosmetic / anti‑ageing trials

Multiple controlled human studies show consistent improvements in skin structure and appearance:

• 12‑week facial trial (71 women)

  • Increased skin density & thickness

  • Reduced laxity, fine lines, wrinkle depth

  • Improved clarity and firmness

• Eye‑area trial (41 women)

  • Outperformed placebo and vitamin K

  • Reduced wrinkles, improved density and thickness

• Thigh skin collagen trial

  • Collagen increased in 70% of GHK‑Cu users

  • Compared to 50% with vitamin C and 40% with retinoic acid

• Randomised double‑blind trial (nano‑lipid GHK‑Cu)

  • 31.6% wrinkle volume reduction vs Matrixyl 3000

  • 55.8% wrinkle volume reduction vs control serum

  • 32.8% wrinkle depth reduction

GHK‑Cu gel for acute wounds (ongoing trial)

ClinicalTrials.gov lists an active study: Topical GHK‑Cu Gel for Acute Skin Wound Healing (NCT07437586). Results are not yet posted, but the trial confirms regulatory interest in human wound‑healing applications.

What trials suggest mechanistically

Human trials align with mechanistic data showing:

• Increased collagen, elastin, glycosaminoglycans

• Improved fibroblast activity

• Reduced inflammatory cytokines

• Enhanced epithelial repair

• Gene expression “resetting” toward a younger profile (based on genomic mapping)

These mechanistic effects explain why even low‑dose topical GHK‑Cu produces visible improvements in skin thickness, healing speed, and wrinkle reduction.

Summary — What clinical trials reveal: